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Abstract
Magnesium alloys have been investigated in different fields of medicine and represent a promising biomaterial for implants
due to characteristics like bioabsorbability and osteoinduction. The objective of this study was to evaluate the usability of
magnesium as implant material in middle ear surgery. Magnesium implants were placed into the right middle ear of
eighteen New Zealand White rabbits. Nine animals were euthanized after four weeks and nine animals after three
month. The petrous bones were removed and embedded in epoxy resin. The specimens were then polished, stained and
evaluated with the aid of a light microscope. The histological examination revealed a good biocompatibility. After four
weeks, a beginning corrosion of the implant’s surface and low amount of trabecular bone formation in the area of the
stapes base plate was observed. A considerable degradation of implants and obvious bone formation was found three
month after implantation. The magnesium alloy used in the present study partly corroded too fast, so that a complete
bone reconstruction could not be established in time. The increased osteoinduction on the stapes base plate resulted in
a tight bone-implant bonding. Thus, a promising application of magnesium could be a coating of biomaterials in order to
improve the bony integration of implants.
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Introduction
Today, materials that are commonly used for total ossi-
cular replacement prostheses (TORP) like autogenic
ossicles or alloplastic materials such as titan1 are
permanent implants, which are inserted to reconstruct
destroyed ossicles to restore the transmission of sound
from the tympanic membrane to the inner ear. These
materials remain in the human body and increase the
risk for infections or, in case of autogenic ossicles, pro-
mote the recurrence of the initial disease. To avoid
these problems and the need for a follow-up operation
for implant removal in orthopedics, bioabsorbable
materials which degrade after serving their purpose
were investigated.2,3 In orthopaedics, especially poly-
mers like polyglycolic acid and polylactic acid were
used as plates or screws, but showed adverse eﬀects
like local tissue reactions.4 The same polymers were
examined as cardiovascular devices such as coronary
stents, but revealed excessive neointima proliferation
with complete occlusion of vessels and inﬂammatory
reactions.5
Another material which is bioabsorbable and which
becomes more and more important in implant research
is magnesium. This metal degrades in a corrosion pro-
cess whereas magnesium ions are released and then
removed through phagocytosis.6 As a natural compo-
nent of the human body, magnesium provides a good
biocompatibility.7,8 It possesses no allergic potential9
and causes no distinct inﬂammatory reactions, which
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is demonstrated by many animal experiments.8,10–12
Compared to other biodegradable materials like poly-
mers, magnesium shows higher mechanical strength
and fracture toughness.7,13 Furthermore, it is reported
that magnesium has an osteoinductive12 and osteocon-
ductive eﬀect.8,12–14 While osteoblasts are stimulated
and new bone develops, the implant disappears grad-
ually and a follow-up surgery to remove the implant is
not necessary. This decreases costs, anesthetic risks and
adverse psychological eﬀects on the patients.2,3 In
orthopedics, screws or plates made of magnesium
alloys have been investigated13 as well as magnesium
scaﬀolds for cartilage repair that promote peri-implant
bone remodelling.6 Positive results have not only been
presented in orthopedics but especially in cardiac sur-
gery, where magnesium is used as basic material for the
manufacture of intravascular stents. Implantation in
humans showed absorption of magnesium stents and
replacement by tissue without excess restenosis.5,7
Even children have been provided with magnesium
stents, which presents a special challenge because of
further growth and therefore risk of restenosis. For
example, Zartner et al.15 described the successful
implantation of a biodegradable magnesium stent into
the left pulmonary artery of a preterm baby because of
a previous inadvertent ligation of this artery. In this
study, we wanted to investigate whether magnesium
could serve as a material in middle ear surgery as
well. With focus on ossiﬁcation, we examined histolo-
gically the replacement of magnesium implants with
endogenous bone to build up a new ossicular chain in
the rabbit’s middle ear.
Materials and methods
The TORPs consisted of magnesium alloy ZEK 100,
produced by the Institute of Materials Science,
Leibniz University Hannover. This alloy is composed
of 98.4wt% magnesium, 1.4wt% zinc, 0.1wt% zirco-
nium, 0.1wt% rare earth elements (cerium/lanthan/
neodymium/praseodym) and oﬀers an initial tensile
strength.16 The cylindrical implants (Figure 1) were
manufactured with a length of 2mm and a diameter
of 1mm and were sterilized with plasma sterilization
before implantation.
For the animal experiment (Ref: 33.9-42502-04-09/
1735, administrative district council of Hannover), 18
female New Zealand White rabbits, weighting from 3 to
3.3 kg, were obtained from the laboratory animal
breeding farm Charles River in Sulzfeld, Germany.
The rabbits were kept adequately in the Institute for
Laboratory Animal Science and Central Animal
Facility of Hannover Medical School, Germany.
The sedation of the rabbits was performed with an
intramuscular injection of ketamin (Ketamin Gra¨ub,
25mg/kg, Albrecht, Aulendorf, Germany) and midazo-
lam (Midazolam-ratiopharm, 1.25mg/kg, ratiopharm,
Ulm, Germany). The animals got carprofen (Rimadyl,
4mg/kg s.c., Pﬁzer, Berlin, Germany) and buprenor-
phin (Temgesic, 0.05mg/kg s.c., Essex Pharma,
Mu¨nchen, Germany) for pain treatment and glycopyr-
roniumbromid (Robinul, 0.1mg/kg s.c., Riemser,
Germany) to reduce side eﬀects of the anaesthetics.
The eyes of the rabbits were protected with ophthalmic
ointment (BepanthenAugen- und Nasensalbe, Bayer,
Leverkusen, Germany). Propofol (Propofol-Lipuro
1%, 2mg/kg i.v., B. Braun, Melsungen, Germany)
was given intravenously through the auricular vein to
enable the intubation. During surgery, inhalation of
isoﬂuran (Isoﬂuran, Baxter, Unterschleißheim,
Germany) continued anaesthesia and electrolyte solu-
tion (Sterofundin-HEG-5, 10mL/kg/h, B. Braun,
Melsungen, Germany) stabilized the rabbits’ circula-
tion. After shaving the operating area closely, the dis-
infection was done with povidon jodine (Braunol,
B. Braun, Melsungen, Germany).
The prostheses were implanted into the right middle
ear of the rabbits. A laser microscope (OPMI Twin ER,
Carl Zeiss AG, Oberkochen, Germany) was used
during surgery. The external acoustic meatus was
exposed through a retroauricular incision of the skin
and the division of the muscles. The meatus was
opened and after dissection of a tympanomeatal ﬂap,
the posterior wall of the external auditory canal was
removed to get access to the tympanic cavity. After
removing the ossicles, the prostheses were positioned
between the tympanic membrane and the stapes base
plate without special ﬁxation. Then the tympanomeatal
ﬂap was replaced and a tamponade (Gelita, B. Braun,
Melsungen, Germany) was used to close the external
Figure 1. Cylindrical magnesium alloy implant.
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auditory canal. Non-absorbable surgical suture mater-
ial (Supolene, RESORBA Wundversorgung,
Nu¨rnberg, Germany) was used to close the wound rims.
The rabbits were examined twice a day, whereas
their clinical general condition and the wound area
were documented. To avoid inﬂammatory response
and pain, the animals got carprofen (Rimadyl, 4mg/
kg s.c., Pﬁzer, Berlin, Germany) for 2 days.
Additionally, enroﬂoxacin (Baytril, 5mg/kg s.c.,
Bayer, Leverkusen, Germany) was given as antibiotic
prophylaxis for 10 days. In case of neurological dis-
orders as a result of auditory nerve irritation, we
administered vitamin B1 (Betabion100mg, 10mg/kg
p.o., Merck Serono, Darmstadt, Germany) and vitamin
B6 (Vitamin B6-Hevert Tabletten, 5 mg/kg p.o.,
Hevert-Arzneimittel, Nussbaum, Germany) to support
neurological function as well as prednisolone (Solu-
Decortin, 1mg/kg s.c., Merck Pharma, Darmstadt,
Germany) to treat swelling.
The rabbits were assigned to two groups, whereas
one group (group 1, n¼ 9) was euthanized after
4 weeks and the other group (group 2, n¼ 9) after
3 months. After sedation with ketamin (Ketamin
Gra¨ub, 25mg/kg i.m., Albrecht, Aulendorf,
Germany) and midazolam (Midazolam-ratiopharm,
1.25mg/kg i.m., ratiopharm, Ulm, Germany), the rab-
bits received propofol intravenously (Propofol-Lipuro
1%, 2mg/kg i.v., B. Braun, Melsungen, Germany)
and were then euthanized with pentobarbital
(Release, 600mg/kg i.v., WDT, Garbsen, Germany).
Immediately after determining the death, the middle
ears were ﬁxed with paraformaldehyde (4%) through
the tympanic membrane. The petrous bones were
removed and stored in 4% paraformaldehyde before
dehydrating the specimens with increasing concentra-
tions of ethanol. The petrous bones were dried by
65C for 24 h and then embedded in epoxy resin
(SpeciFix 20 Kit, Struers A/S, Rodovre, Denmark)
under vacuum conditions. The specimens were ground
and polished using a grinding machine (LaboPol-5,
Struers A/S, Rodovre, Denmark) and stained with a
modiﬁed staining by Mann-Dominici, consisting of
0.5% Toluidine blue (Sigma, St. Louis, USA), 0.1%
Eosine G (Merck, Darmstadt, Germany) and 0.25%
Orange G (Merck, Darmstadt, Germany). The histo-
logical examination was done with the aid of a light
microscope (VHX-600, 20–200magniﬁcation,
Keyence Corporation, Osaka, Japan) with integrated
imaging software for recording every grinding plane.
Degradation of the implants and ossiﬁcation were
evaluated on the basis of a scoring system (Table 1)
and are expressed as the mean of each group.
Results
The postoperative period passed oﬀ without complica-
tions except for two animals suﬀering from nystagmus
and slight head tilt due to an irritation of the auditory
nerve during surgery. Four other rabbits showed mild
inﬂammatory reactions of the wound area for about
3 days. Overall, we did not observe any impairment
of the rabbits’ general condition or severe inﬂammation
with delayed wound healing.
The macroscopic examination of the right outer ear
after euthanasia revealed a smaller lumen of the exter-
nal auditory canal than the auditory canal of the left
ear. In the histological examination, the mucosa of the
external auditory canal was not thickened and no
inﬂammatory reactions were observed (Figure 2(a) to
(c)). In the lumen of the auditory canal, little amount of
detritus and residues of the tamponade were found. The
tympanic membrane was injured when ﬁxation of the
middle ear was performed (Figure 2(b)), but apart from
that no alterations were determined.
Three implants were dislocated after 4 weeks, the
other six implants of group 1 were found in the area
of the stapes base plate. In group 2, the correct position
of the implants in three specimens was evaluated by
Table 1. Evaluation of the histological findings. Degradation and ossification of the magnesium alloy
implants.
Score Degradation
0 No degradation
1 Minor degradation (beginning degradation on the surface of the implant)
2 Substantial degradation (loss of structure of the implant because of degradation)
3 Complete degradation
Score Ossification
0 No bone formation
1 Little bone formation (few bone trabeculae)
2 Increased bone formation (obvious trabecular bone structure)
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newly formed tissue in the area of the stapes base plate
because of the advanced degradation of the magne-
sium. One of these specimens revealed no ossiﬁcation,
so that the implant might be dislocated. Another spe-
cimen of this group revealed a dislocated implant, but
also newly formed bone tissue on the stapes base plate,
so that this implant could be dislocated during prepar-
ation. All other implants in this group were not dislo-
cated. The specimens with dislocated implants have
also been included in the evaluation, because of the
assumption that degradation process and ossiﬁcation
of dislocated and not dislocated implants were similar.
As expected, no signs of inﬂammation were observed
in the surrounding tissue of the implant. The mucosa of
the middle ear was not thickened and appeared regular
in all specimens. In case of less degraded implants, a
mucosal coverage could be observed (72%, n¼ 9).
Furthermore, the surrounding tissue revealed no signs
of disorders due to gas production as a result of the
degradation process.
The histological examination showed a beginning
corrosion of the implant’s surface after 4 weeks and
an increased degradation of all implants after
3 months (Table 2, Figure 3).
Production of new bone was found especially in the
area of the stapes base plate, where the implants had
been placed in direct contact to bone tissue.
Additionally, newly formed bone was observed, when
Mg was in contact to remaining ossicles. The new tissue
appeared as trabecular bone structure and always con-
tacted the implant surface. After 4 weeks (Figure 4),
increased bone formation was found in 22.2% (n¼ 9)
(score 2), while 44.4% (n¼ 9) showed already little
bone like matrix formation. The specimens, which
were harvested after 3 months (Figure 5), presented
increased bone formation in 55.6% (n¼ 9) (score 2)
whereas 33.3% of the nine samples showed little bone
formation and where allocated to score 1. Table 3
Figure 2. Mucosal coverage of the external auditory canal: (a) specimen of a physiological left middle ear with the intact tympanic
membrane and malleus; (b) specimen after 4 weeks of implantation showing a regular mucosa and the injured tympanic membrane due
to the preparation process; (c) higher magnification of the unaffected mucosa; Mu¼Mucosa, Tm¼Tympanic membrane,
Ma¼Malleus.
Table 2. Degradation of magnesium alloy
implants after 4 weeks (a) and 3 months (b).
Degradation
score
Percentage of
specimens, n¼ 9
(a) after 4 weeks
0 0
1 33.3
2 55.6
3 11.1
(b) after 3 months
0 0
1 0
2 66.7
3 33.3
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shows the correlation between degradation rate and
new bone formation.
Discussion
The purpose of this study was to examine the applic-
ability of magnesium as basic material for ossicular
replacement prostheses. In a rabbit model, the ossicles
were replaced by cylindrical implants consisting of the
magnesium alloy ZEK 100 which was chosen because
of its high content of magnesium. As there are to our
knowledge no other studies dealing with the behaviour
of magnesium in the middle ear, we initially wanted to
investigate the characteristics of almost pure magne-
sium in this location. The implants were positioned
on the stapes footplate to induce ossiﬁcation and thus
building up a new ossicular chain similar to a columella
consisting of endogenous bone.
Magnesium corrodes in aqueous media releasing
magnesium ions. After implantation, these ions are
Figure 4. Ossification after 4 weeks of implantation. Overview of a specimen with little bone formation (a) and a specimen with
increased bone formation (c); higher magnification (b: marked area of a, d: marked area of c) showing the new bone formation in the
area of the stapes base plate (between the black arrows). Mg¼Magnesium alloy implant, N¼New bone formation.
Figure 3. Specimens after 4 weeks of implantation with different degradation scores: (a) degradation score 1; (b) degradation
score 2.
(a) Beginning corrosion on the surface of a magnesium alloy implant, the structure of the cylindrical prostheses is still recognizable.
(b) Substantial degradation of a magnesium alloy implant, the ends of the prostheses have almost been degraded completely.
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absorbed by the body and excreted or utilized in the
body’s metabolism. The physiological magnesium ion
concentration is regulated by the kidneys and intes-
tine.13 A beneﬁcial characteristic of magnesium as
implant material is the osteoinduction (stimulation of
new bone formation) capacity. As a result, endogenous
bone replaces the degraded implant and a second sur-
gery for implant removal is not necessary.8,12,13
Furthermore, the foreign body has disappeared and
the risk for infection is thereby reduced.2
In this study, degradation of magnesium alloy
implants and new bone formation was demonstrated
in a living organism. The two study groups revealed
diﬀerent degradation stages in correlation with varying
extents of ossiﬁcation. A well-known problem of many
magnesium alloys investigated is the high corrosion rate
depending on the environment.11,12 It has been docu-
mented, that there are obvious diﬀerences in degrad-
ation rates of magnesium alloy implants at various
sites of the body.11 Especially chloride containing aque-
ous media like the physiological body ﬂuid leads to a
fast degradation of magnesium,7,13 whereas in atmos-
phere a natural oxide ﬁlm on the surface protects mag-
nesium from corrosion.17–19 Therefore we assumed that
in middle ear surgery with an air-ﬁlled location, the
degradation may be reduced and osteoinduction could
be performed. After 4 weeks, the specimens showed
diﬀerent progress of corrosion ranging from minor to
Figure 5. Ossification after 3 months of implantation. Specimen with little bone formation (a) (score 1); Specimen with increased
bone formation (b, c, d) (score 2). Black arrows mark the area of the stapes base plate, N¼New bone formation, Mg¼Residual
magnesium alloy implant.
Table 3. Comparison of degradation and ossification after
4 weeks (a) and 3 months (b).
Specimen
New bone
formation
(score 0–2)
Degradation
(score 0–3)
(a) after 4 weeks
1 2 1
2 0 2
3 1 1
4 1 2
5 2 2
6 0 3
7 1 1
8 1 2
9 0 2
(b) after 3 months
1 2 2
2 0 3
3 1 3
4 2 2
5 2 2
6 1 2
7 2 2
8 2 2
9 1 3
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complete degradation. A possible explanation for this
variability could be diﬀerences in the amount of wound
secretion during and after surgery. In group 1 for exam-
ple, an increased bleeding occurred during surgery
in one rabbit. In the histological examination this
specimen showed no ossiﬁcation and a complete
degradation.
Another disadvantage of magnesium described in
literature is the production of gas during the corrosion
process.13,20 In a study of Witte et al.,20 gas was
observed clinically as subcutaneous gas bubbles
around the guinea pig femora and was also documented
by radiography. Similar results were noticed in a rabbit
model, which demonstrated also the correlation
between the degradation rate and the generation
of gas.21
In this study, obvious gas production was neither
found in the clinical examination nor in the histological
specimens. A possible reason could be again the air-
ﬁlled location in contrast to body ﬂuid containing
sites like the femur or other positions mentioned in
the studies before. Thus in the middle ear, magnesium
ions come into contact with body ﬂuid to a lesser extent
so that gas production is inhibited. Furthermore, gas is
resorbed by the organism up to a certain point,22 so
that the organism can manage a little amount of gas
this way. Greater quantities of gas and the following
increased pressure in the middle ear could also be com-
pensated by the Eustachian tube, so that this conse-
quence of magnesium corrosion may be irrelevant at
this location.
In contrast to other researchers,21 we noticed a cor-
relation between new bone formation and the degrad-
ation rate. The more advanced the implant
degradation, the smaller was the bone tissue formation
(Table 3). After 4 weeks, most of the specimens showed
already increased corrosion, but also few bone like
matrix formation. Two implants of this group revealed
beginning corrosion. In consequence, obvious ossiﬁca-
tion was found in the area of the stapes base plate.
In three cases no bone formation could be detected.
The specimens without new bone showed in one case
a highly degraded implant and in the other two cases
dislocated implants. This result demonstrates the
importance of the contact between the implant and
bone, because magnesium induces diﬀerentiation and
growth of stromal cells towards an osteoblast-like
phenotype23,24 implying a direct connection of the
metal with tissue cells. After 3 months, most of the spe-
cimens showed increased degradation of the implants,
but also obvious bone formation. Three implants were
completely degraded. Two of them induced only a
minor ossiﬁcation on the stapes base plate. This sug-
gests the right position of the implants, but a degrad-
ation process too fast to initiate more newly formed
bone tissue. In the other specimen no new bone forma-
tion was found, so that this implant might be dislocated
and osteoinduction failed.
Although osteoinduction was proved, it has to be
point out that the magnesium alloy tested in the present
study seems not to be appropriate as basic material for
ossicular replacement prostheses. Even in an air-ﬁlled
location like the middle ear, the corrosion rate of this
magnesium alloy is too fast and a proliferation of bone
tissue in the form of a columella was not found, so that
a connection to the tympanic membrane could not be
established.
There are many studies dealing with the inﬂuence of
alloying elements, manufacture processing, heat treat-
ment and other options to slow down the corrosion
rate.7,13,20 A possible way to enable the application of
bioabsorbable magnesium for total ossicular replace-
ment prostheses could be the development of magne-
sium alloys with reduced degradation rates to improve
new bone tissue formation.
Furthermore an opportunity to provide a better
osteoconductive structure for new bone formation
could be the use of porous magnesium implants.
There are many studies which demonstrate the
enhanced osteogenesis of porous versus solid
implants.25 This is due to the property of pores to
allow migration and proliferation of osteoblasts and
mesenchymal cells, as well as vascularization,26 result-
ing in a better nutritional situation. When using porous
materials, the appropriate choice of pore size is import-
ant, because pore volume and size aﬀect the mechanical
properties.13,25 Additionally, the degradation rate is
necessary, because materials with high degradation
rates should not have high porosity since rapid deple-
tion of the biomaterial will compromise the mechanical
integrity.14,25
Another promising application of the metal magne-
sium in middle ear surgery could be a magnesium coat-
ing for the purpose of a tighter connection between
implant and stapes base plate. The bone–implant bond-
ing is very important to prevent implant extrusion and
therefore to ensure a correct sound transmission.1,27
In previous studies the positive eﬀect of surface modi-
ﬁcation of diﬀerent materials with magnesium ions was
demonstrated.27–29 Zreiqat et al.27 showed an increase
in osteoblast adhesion to alumina modiﬁed with mag-
nesium and showed also the characteristic of magne-
sium to enhance the diﬀerentiation of cells, which is
the deciding step for a tighter bone–implant bonding.25
In a study performed by Revell et al.,28 an increased
interfacial strength of hydroxyapatite implants enriched
with magnesium was found. Similar positive eﬀects of
magnesium coated materials are shown in a study of
Yamasaki et al.29 In middle ear surgery, a partial mag-
nesium coating on the site which will be in contact to
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the stapes base plate could be helpful to strengthen the
bone–implant bonding.
In conclusion, the present animal model conﬁrms
the good biocompatibility and osteoconduction of
magnesium. A possible application in middle ear
surgery could be a modiﬁcation of common materials
with magnesium ions to improve integration of middle
ear implants, especially in the area of the stapes
base plate.
Conclusion
The present animal study proves the degradation and
the biocompatibility of magnesium alloy ZEK 100 in
the rabbit’s middle ear, while new bone tissue was
formed especially in the area of the stapes base plate.
The magnesium alloy used in the present study partly
corroded too fast, so that a complete bone reproduc-
tion in form of a columella could not be established.
Further research concerning the degradation rate is
needed to enable the application of magnesium as
basic material in middle ear surgery. Regarding the
new bone formation at the stapes base plate, our ﬁnd-
ings demonstrates the increased osteoconduction on
this position resulting in a tight bone–implant bonding.
Therefore a possible application of magnesium could
also be a coating of middle ear prostheses in order to
improve the integration of the implants.
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